The People behind the Tiny Revolution

Screen Shot 2015-10-29 at 4.09.23 PM.png


Martha Carlin, CEO

CEO, BioCollective Research and The BioCollective; Investor/advisor, Pure Cultures and Amazigh; Executive Vice President operations, UDR; VP Operations, Ops Technology; Chief Financial Officer, Wentwood Investment Partners; consultant/manager, Arthur Andersen.



Suzanne D. Vernon, PhD.

Chief Scientific Officer, BioCollective Research and The BioCollective; Scientific Director, Solve ME/CFS Initiative; driving force behind creation of SolveCFS BioBank, an integrated patient registry and sample biorepository; author and co-author of more than 90 peer-reviewed publications; Team Leader of the Centers for Disease Control and Prevention.



Jack Gilbert, PhD.

Associate Professor in the Departments of Ecology and Evolution and Surgery; Associate DirectorInstitute for Genomics and Systems Biology; Group Leader, Microbial Ecology, Argonne National Laboratory; Senior ScientistMarine Biological Laboratory;  Popular Science Top 10 Young Scientists in America and Top 50 Scientists Changing the World

Board of Directors

Linda Avey

CEO and founder of We Are Curious, Inc.; co-Founder of 23andMe, Inc.; founded Brainstorm Research Foundation, which focuses on accelerating research in Alzheimer’s disease; developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences; worked at Spotfire helping scientists understand the power of data visualization and at Applied BioSystems during the early days of the human genome project

Bernard Munos

Founder and chief apostle of InnoThink, a consultancy focused on pharmaceutical innovation; Senior Fellow at FasterCures, a center of the Milken Institute; serves on various boards and advisory bodies, including NCATS, the Institute of Medicine, Glenmark Pharmaceuticals, think tanks and foundations

Mark Muller, PhD.

Founder and CEO of TopoGEN, Inc., a winner of the Edison Prize as most innovative start-up company in Ohio; leading force in successful academic research programs funded by NIH, ACS, NSF and various state and local agencies; founder of biotechnology startups, including Visual Genomics, Methylation Ltd., DNA Protein, Ltd.; past Director of the Cancer Research Consortium of Central Florida; Director of the Experimental Therapeutics Program at The Ohio State University Comprehensive Cancer Center (an NCI designated cancer center); co-founder of the first Department of Molecular Genetics in the U.S. while on faculty at Ohio State University